SAB Biotherapeutics
Price & Volume
Stats
See more52W Range | $1-$4.60 |
Market Cap | $172.3M |
Shares Short | 901,471 |
Financials
See moreRevenue (12 Mos) | $114,698 |
Revenue Growth (YoY) | -62.4% |
Gross Profit (12 Mos) | -$30.3M |
Diluted EPS | -$1.56 |
News
See moreYahoo Finance • 23 days ago
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D
Yahoo Finance • last month
SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management
Yahoo Finance • 2 months ago
SAB Biotherapeutics reports Q3 results
Yahoo Finance • 2 months ago
SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights
About
CEO | Mr. Samuel J. Reich |
CFO | Ms. Lucy To |
Address | 777 W 41st St., Miami Beach, FL, United States, 33140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 63 |
